MARCH-APRIL 2018 |
Michael Wendt, an assistant professor of medicinal chemistry and molecular pharmacology, has received a National Cancer Institute grant for his project, “Overcoming Metastatic Resistance to Erbb-Targeted Therapies.” He is one of the award recipients noted in a recent Sponsored Program Awards listing.
A comprehensive monthly awards list, including search and sort capabilities, is available on the Executive Vice President for Research and Partnerships website. Awards are posted two months behind the current month, and both PDF and Excel files are available.
The awards list is generated by Sponsored Program Services. Questions concerning the information contained in this section should be directed to Stephanie Willis.